Axsome Therapeutics (AXSM) EBIT Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -115.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -115.01% |
| Dec 31, 2025 | 54.54% |
| Sep 30, 2025 | -2.83% |
| Jun 30, 2025 | 2.14% |
| Mar 31, 2025 | -14.17% |
| Dec 31, 2024 | -30.59% |
| Sep 30, 2024 | -23.30% |
| Jun 30, 2024 | -36.26% |
| Mar 31, 2024 | -34.19% |
| Dec 31, 2023 | -52.44% |
| Sep 30, 2023 | -43.26% |
| Jun 30, 2023 | -54.10% |
| Mar 31, 2023 | 41.89% |
| Dec 31, 2022 | -34.86% |
| Sep 30, 2022 | -30.81% |
| Jun 30, 2022 | -42.82% |
| Mar 31, 2022 | -54.31% |
| Dec 31, 2021 | -75.99% |
| Sep 30, 2021 | -59.43% |
| Jun 30, 2021 | -56.88% |
| Mar 31, 2021 | -57.23% |
| Dec 31, 2020 | -84.74% |
| Sep 30, 2020 | -74.95% |
| Jun 30, 2020 | -66.71% |
| Mar 31, 2020 | -84.05% |
| Dec 31, 2019 | -73.29% |
| Sep 30, 2019 | -66.66% |
| Jun 30, 2019 | -58.34% |
| Mar 31, 2019 | -55.66% |
| Dec 31, 2018 | 44.16% |
| Sep 30, 2018 | -82.45% |
| Jun 30, 2018 | -80.00% |
| Mar 31, 2018 | -78.69% |